- Latest available (Revised)
- Original (As adopted by EU)
Commission Regulation (EC) No 1662/2006 of 6 November 2006 amending Regulation (EC) No 853/2004 of the European Parliament and of the Council laying down specific hygiene rules for food of animal origin (Text with EEA relevance)
When the UK left the EU, legislation.gov.uk published EU legislation that had been published by the EU up to IP completion day (31 December 2020 11.00 p.m.). On legislation.gov.uk, these items of legislation are kept up-to-date with any amendments made by the UK since then.
Legislation.gov.uk publishes the UK version. EUR-Lex publishes the EU version. The EU Exit Web Archive holds a snapshot of EUR-Lex’s version from IP completion day (31 December 2020 11.00 p.m.).
This version of this Regulation was derived from EUR-Lex on IP completion day (31 December 2020 11:00 p.m.). It has not been amended by the UK since then. Find out more about legislation originating from the EU as published on legislation.gov.uk.
Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.
In Section I, Chapter IV is amended as follows:
Point 8 is replaced by the following:
Point 16(a) is replaced by the following:
the tonsils of bovine animals, porcine animals and solipeds must be removed hygienically;’.
In Section VIII, Chapter III, Part E is added as follows:
Food business operators must ensure that raw materials used in the preparation of fish oil for human consumption comply with the following requirements:
they must derive from fishery products which have been found fit for human consumption;
they must come from establishments, including vessels, approved in accordance with this Regulation;
they must be transported and stored until processing in hygienic conditions.’
Section IX is replaced by the following:
For the purpose of this Section,
“Colostrum” means the fluid secreted by the mammary glands of milk-producing animals up to three to five days post parturition that is rich in antibodies and minerals, and precedes the production of raw milk.
“Colostrum-based products” means processed products resulting from the processing of colostrum or from the further processing of such processed products.
Food business operators producing or, as appropriate, collecting raw milk and colostrum must ensure compliance with the requirements laid down in this Chapter.
that do not show any symptoms of infectious diseases communicable to humans through milk and colostrum;
that are in a good general state of health, present no sign of disease that might result in the contamination of milk and colostrum and, in particular, are not suffering from any infection of the genital tract with discharge, enteritis with diarrhoea and fever, or a recognisable inflammation of the udder;
that do not have any udder wound likely to affect the milk and colostrum;
to which no unauthorised substances or products have been administered and that have not undergone illegal treatment within the meaning of Directive 96/23/EC;
in respect of which, where authorised products or substances have been administered, the withdrawal periods prescribed for these products or substances have been observed.
In particular, as regards brucellosis, raw milk and colostrum must come from:
cows or buffaloes belonging to a herd which, within the meaning of Directive 64/432/EEC(1), is free or officially free of brucellosis;
sheep or goats belonging to a holding officially free or free of brucellosis within the meaning of Directive 91/68/EEC(2); or
females of other species belonging, for species susceptible to brucellosis, to herds regularly checked for that disease under a control plan that the competent authority has approved.
As regards tuberculosis, raw milk and colostrum must come from:
cows or buffaloes belonging to a herd which, within the meaning of Directive 64/432/EEC, is officially free of tuberculosis; or
females of other species belonging, for species susceptible to tuberculosis, to herds regularly checked for this disease under a control plan that the competent authority has approved.
If goats are kept together with cows, such goats must be inspected and tested for tuberculosis.
in the case of cows or buffaloes that do not show a positive reaction to tests for tuberculosis or brucellosis, nor any symptoms of these diseases, after having undergone a heat treatment such as to show a negative reaction to the alkaline phosphatase test;
in the case of sheep or goats that do not show a positive reaction to tests for brucellosis, or which have been vaccinated against brucellosis as part of an approved eradication programme, and which do not show any symptom of that disease, either:
for the manufacture of cheese with a maturation period of at least two months; or
after having undergone heat treatment such as to show a negative reaction to the alkaline phosphatase test; and
in the case of females of other species that do not show a positive reaction to tests for tuberculosis or brucellosis, nor any symptoms of these diseases, but belong to a herd where brucellosis or tuberculosis has been detected after the checks referred to in point 2(a)(iii) or 2(b)(ii), if treated to ensure its safety.
that, before milking starts, the teats, udder and adjacent parts are clean;
that milk and colostrum from each animal is checked for organoleptic or physico-chemical abnormalities by the milker or a method achieving similar results and that milk and colostrum presenting such abnormalities is not used for human consumption;
that milk and colostrum from animals showing clinical signs of udder disease are not used for human consumption otherwise than in accordance with the instructions of a veterinarian;
the identification of animals undergoing medical treatment likely to transfer residues to the milk and colostrum, and that milk and colostrum obtained from such animals before the end of the prescribed withdrawal period are not used for human consumption; and
that teat dips or sprays are used only after authorisation or registration in accordance with the procedures laid down in Directive 98/8/EC of the European Parliament and of the Council of 16 February 1998 concerning the placing of biocidal products on the market(3):
that colostrum is milked separately and not mixed together with raw milk.
Milk must be cooled immediately to not more than 8 oC in the case of daily collection, or not more than 6 oC if collection is not daily;
Colostrum must be stored separately and immediately cooled to not more than 8 oC in the case of daily collection, or not more than 6 oC if collection is not daily, or frozen.
the milk is processed within two hours of milking; or
a higher temperature is necessary for technological reasons related to the manufacture of certain dairy products and the competent authority so authorises.
The following criteria for raw milk apply pending the establishment of standards in the context of more specific legislation on the quality of milk and dairy products.
National criteria for colostrum, as regards plate count, somatic cell count or antibiotic residues, apply pending the establishment of specific Community legislation.
the food business operator producing the milk;
the food business operator collecting or processing the milk;
a group of food business operators; or
in the context of a national or regional control scheme.
Food business operators must initiate procedures to ensure that raw milk meets the following criteria:
for raw cows' milk:
a Rolling geometric average over a two-month period, with at least two samples per month. | |
b Rolling geometric average over a three-month period, with at least one sample per month, unless the competent authority specifies another methodology to take account of seasonal variations in production levels. | |
Plate count at 30 oC (per ml) | ≤ 100 000a |
Somatic cell count (per ml) | ≤ 400 000b |
for raw milk from other species:
a Rolling geometric average over a two-month period, with at least two samples per month. | |
Plate count at 30 oC (per ml) | ≤ 1 500 000a |
However, if raw milk from species other than cows is intended for the manufacture of products made with raw milk by a process that does not involve any heat treatment, food business operators must take steps to ensure that the raw milk used meets the following criterion:
a Rolling geometric average over a two-month period, with at least two samples per month. | |
Plate count at 30 oC (per ml) | ≤ 500 000a |
it contains antibiotic residues in a quantity that, in respect of any one of the substances referred to in Annexes I and III to Regulation (EEC) No 2377/90(4), exceeds the levels authorised under that Regulation; or
the combined total of residues of antibiotic substances exceeds any maximum permitted value.
milk is quickly cooled to not more than 6 oC;
colostrum is quickly cooled to not more than 6 oC or maintained frozen,
and kept at that temperature until processed.
processing begins immediately after milking, or within four hours of acceptance at the processing establishment; or
the competent authority authorises a higher temperature for technological reasons concerning the manufacture of certain dairy or colostrum-based products.
Pasteurisation is achieved by a treatment involving:
a high temperature for a short time (at least 72 oC for 15 seconds);
a low temperature for a long time (at least 63 oC for 30 minutes); or
any other combination of time-temperature conditions to obtain an equivalent effect,
such that the products show, where applicable, a negative reaction to an alkaline phosphatase test immediately after such treatment.
Ultra high temperature (UHT) treatment is achieved by a treatment:
involving a continuous flow of heat at a high temperature for a short time (not less than 135 oC in combination with a suitable holding time) such that there are no viable microorganisms or spores capable of growing in the treated product when kept in an aseptic closed container at ambient temperature, and
sufficient to ensure that the products remain microbiologically stable after incubating for 15 days at 30 oC in closed containers or for seven days at 55 oC in closed containers or after any other method demonstrating that the appropriate heat treatment has been applied.
have regard to the procedures developed in accordance with the HACCP principles pursuant to Regulation (EC) No 852/2004; and
comply with any requirements that the competent authority may impose in this regard when approving establishments or carrying out checks in accordance with Regulation (EC) No 854/2004.
raw cows' milk used to prepare dairy products has a plate count at 30 oC of less than 300 000 per ml; and
processed cows' milk used to prepare dairy products has a plate count at 30 oC of less than 100 000 per ml.
Sealing of consumer packages must be carried out immediately after filling in the establishment where the last heat treatment of liquid dairy products and colostrum-based products, takes place by means of sealing devices that prevent contamination. The sealing system must be designed in such a way that, after opening, the evidence of its opening remains clear and easy to check.
in the case of raw milk intended for direct human consumption, the words “raw milk”;
in the case of products made with raw milk, the manufacturing process for which does not include any heat treatment or any physical or chemical treatment, the words “made with raw milk”;
in case of colostrum, the word “colostrum”;
in case of products made with colostrum, the words “made with colostrum”.
By way of derogation from the requirements of Annex II, Section I:
rather than indicating the approval number of the establishment, the identification mark may include a reference to where on the wrapping or packaging the approval number of the establishment is indicated;
in the case of the reusable bottles, the identification mark may indicate only the initials of the consigning country and the approval number of the establishment.’
In Section XV, Chapter III, point 1 is replaced by the following:
Council Directive 64/432/EEC of 26 June 1964 on animal health problems affecting intra-Community trade in bovine animals and swine (OJ 121, 29.7.1964, p. 1977/64). Directive as last amended by Regulation (EC) No 21/2004 (OJ L 5, 9.1.2004, p. 8).
Council Directive 91/68/EEC of 28 January 1991 on animal health conditions governing intra-Community trade in ovine and caprine animals (OJ L 46, 19.2.1991, p. 19). Directive as last amended by Commission Decision 2005/932/EC.
OJ L 123, 24.4.1998, p. 1. Directive as last amended by Commission Directive 2006/50/EC (OJ L 142, 30.5.2006, p. 6).
Council Regulation (EEC) No 2377/90 of 26 June 1990 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (OJ L 224, 18.8.1990, p. 1). Regulation as last amended by Commission Regulation (EC) No 1231/2006 (OJ L 225, 17.8.2006, p. 3).’
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As adopted by EU): The original version of the legislation as it stood when it was first adopted in the EU. No changes have been applied to the text.
Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.
Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
This timeline shows the different versions taken from EUR-Lex before exit day and during the implementation period as well as any subsequent versions created after the implementation period as a result of changes made by UK legislation.
The dates for the EU versions are taken from the document dates on EUR-Lex and may not always coincide with when the changes came into force for the document.
For any versions created after the implementation period as a result of changes made by UK legislation the date will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. For further information see our guide to revised legislation on Understanding Legislation.
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: